Conditions: Leukemia
Keywords: Leukemia (chronic myeloid leukemia - chronic phase)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 3
Healthy volunteers: no

Brief summary:
The purpose of this clinical research study is to compare the rate of complete cytogenetic response of dasatinib to imatinib therapy at 6 months after randomization in chronic phase CML patients. The safety of this treatment will also be studied.

Detailed description:

Arms:
arm 1: 50-180 mg once daily (QD) arm 2: 200-800 mg QD

Interventions: intervention 1: Dasatinib intervention 2: Imatinib
Intervention descriptions: intervention 1: Tablets, Oral, Once daily, 5-7 years intervention 2: Tablets, Oral, Once daily, 5-7 years

Protocol document: